207 results
Page 4 of 11
8-K
EX-99.1
mzy f0n96t
1 Feb 21
Prothena Announces Confirmatory Phase 3 AFFIRM-AL Study of Birtamimab in Mayo Stage IV Patients with AL Amyloidosis under SPA Agreement with FDA
4:16pm
SC TO-I/A
EX-99
2259b
28 Jan 21
Issuer tender offer statement (amended)
5:02pm
SC TO-I/A
EX-99
73v v53b6rark1kkv
4 Dec 20
Issuer tender offer statement (amended)
5:01pm
SC TO-I
EX-99
jhekw9qk2 j3t
9 Nov 20
Issuer tender offer statement
9:01am
S-8
EX-23.1
khc5msc
11 Aug 20
Registration of securities for employees
4:20pm
S-8
EX-5.1
cxc9pg24gyo7xxa2
11 Aug 20
Registration of securities for employees
4:20pm
8-K
lt8g20s6x
22 May 20
Departure of Directors or Certain Officers
4:22pm